Company Financials

Akero Therapeutics, Inc. Financials

United States dollar

business Akero Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: AKRO

Market Capitalization $4.50 Billion as of Dec. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -14.57
Forward PE -13.62
Price to Sales TTM $
Price to Book MRQ $4.57
Enterprise to Revenue
Enterprise to EBITDA -11.40

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin 0.00%
Return on Assets TTM -22.63%
Return on Equity TTM -34.53%

Income Statement

Revenue TTM $0
Revenue per Share TTM $0.00
Quarterly Revenue Growth %
Gross Profit TTM $0
EBITDA $-329,987,488
Net Income to Common TTM $-292,820,000
Diluted EPS TTM $-3.75
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $737,825,984
Total Cash per Share MRQ $8.96
Total Debt MRQ $
Total Debt to Equity MRQ 0.06
Current Ratio MRQ 15.84
Book Value per Share MRQ $11.95

Cash Flow

Operating Cash Flow TTM $-250,171,008
Levered Free Cash Flow TTM $-156,879,248

AKRO Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 80,149,218
Float Shares 71,105,539
Avg 10 Volume 4,375,315
Avg 30 Volume None
Shares Short 4,323,058
Short Ratio 2.33
Short % of Shares 5.40%
% Held by Insiders 1.46%
% Held by Institutions 112.47%

Stock Price Summary

Beta -0.40
Fifty Two Week Low $21.34
Fifty Two Week High $58.40
Fifty Two Week Change 49.42%
Day 50 MA $53.20
Day 200 MA $48.24

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date